Researchers are exploring the potential of ultra-sensitive CAR-T cells as a treatment strategy for solid tumors. This approach may offer a new therapeutic option, although the headlines also suggest that the field is still broad and encompasses various areas of research, including chronic viral infections and different types of cancer. The specific outcomes and applications of this strategy are not clearly defined in the available information.